Total Holdings
35
Portfolio diversification across 35 positions
ARKG
(BATS)ARK Genomic Revolution ETF
$28.93-- (--)
Loading... - Market loading
ARKG ETF Holdings: ARK Genomic Revolution ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$1.26B
Total fund assets
Expense Ratio
0.75%
Annual management fee
Fund Issuer
ARK
BATS
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 33 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Twist Bioscience Corporation | Stock | 9.12% |
| 2 |  | Tempus AI, Inc. Class A Common Stock | Stock | 8.90% |
| 3 |  | CRISPR Therapeutics AG | Stock | 8.79% |
| 4 |  | Guardant Health, Inc | Stock | 5.57% |
| 5 |  | Personalis, Inc. | Stock | 5.37% |
| 6 |  | 10x Genomics, Inc. | Stock | 5.06% |
| 7 |  | Beam Therapeutics Inc | Stock | 4.86% |
| 8 |  | Illumina, Inc | Stock | 4.69% |
| 9 |  | Natera, Inc | Stock | 4.48% |
| 10 |  | Recursion Pharmaceuticals, Inc. Class A Common Stock | Stock | 4.24% |
| 11 |  | Veracyte, Inc | Stock | 3.82% |
| 12 |  | Absci Corp | Stock | 3.59% |
| 13 |  | CareDx, Inc. | Stock | 3.39% |
| 14 |  | Schrödinger, Inc | Stock | 3.13% |
| 15 |  | Adaptive Biotechnologies Corporation | Stock | 3.08% |
| 16 |  | Ionis Pharmaceuticals, Inc. | Stock | 2.92% |
| 17 |  | Intellia Therapeutics, Inc. | Stock | 2.89% |
| 18 |  | Nurix Therapeutics, Inc | Stock | 2.22% |
| 19 |  | GeneDx Holdings Corp. | Stock | 1.98% |
| 20 |  | Butterfly Network, Inc | Stock | 1.92% |
| 21 |  | Pacific Biosciences of California, Inc | Stock | 1.76% |
| 22 |  | Arcturus Therapeutics Holdings Inc. | Stock | 1.59% |
| 23 |  | Amgen Inc. | Stock | 1.44% |
| 24 |  | Prime Medicine Inc. Common Stock | Stock | 1.42% |
| 25 |  | Cerus Corporation | Stock | 1.24% |
| 26 |  | COMPASS Pathways plc | Stock | 1.12% |
| 27 |  | Incyte Corporation | Stock | 1.10% |
| 28 |  | Vertex Pharmaceuticals Incorporated | Stock | 0.93% |
| 29 |  | 908 Devices Inc | Stock | 0.86% |
| 30 |  | Caris Life Sciences, Inc. Common Stock | Stock | 0.86% |
| 31 |  | Veeva Systems Inc | Stock | 0.72% |
| 32 |  | Quantum-Si incorporated | Stock | 0.70% |
| 33 | F FLDM | Fluidigm Corporation | Stock | 0.32% |